Salidroside affects the Th17/Treg cell balance in aplastic anemia via the STAT3/HIF-1α/RORγt pathway

References

• Young NS. Aplastic anemia. N Engl J Med. 2018;379(17):1643–1656.
   PubMed Web of Science ®Google Scholar
• Young NS, Maciejewski J. The pathophysiology of acquired aplastic anemia. N Engl J Med. 1997;336(19):1365–1372. doi:10.1056/NEJM199705083361906
   PubMed Web of Science ®Google Scholar
• Solomou EE, Rezvani K, Mielke S, et al. Deficient CD4+ CD25+ FOXP3+ T regulatory cells in acquired aplastic anemia. Blood. 2007;110(5):1603–1606. doi:10.1182/blood-2007-01-066258
   PubMed Web of Science ®Google Scholar
• Solomou EE, Rezvani K, Mielke S, et al. Deficient CD4+ CD25+ FOXP3+ T regulatory cells in acquired aplastic anemia. Blood. 2007;110(5):1603–1606. doi:10.1182/blood-2007-01-066258
   PubMed Web of Science ®Google Scholar
• Zhu J, Paul WE. Peripheral CD4+ T-cell differentiation regulated by networks of cytokines and transcription factors. Immunol Rev. 2010;238(1):247–262. doi:10.1111/j.1600-065X.2010.00951.x
   PubMed Web of Science ®Google Scholar
• Mangan PR, Harrington LE, 'Quinn O, et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature. 2006;441(7090):231–234. doi:10.1038/nature04754
   PubMed Web of Science ®Google Scholar
• Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441(7090):235–238. doi:10.1038/nature04753
   PubMed Web of Science ®Google Scholar
• Lee GR. The balance of Th17 versus Treg cells in autoimmunity. Int J Mol Sci. 2018;19(3):730–744.
   PubMed Web of Science ®Google Scholar
• Littman DR, Rudensky AY. Th17 and regulatory T cells in mediating and restraining inflammation. Cell. 2010;140(6):845–858. doi:10.1016/j.cell.2010.02.021
   PubMed Web of Science ®Google Scholar
• de Latour RP, Visconte V, Takaku T, et al. Th17 immune responses contribute to the pathophysiology of aplastic anemia. Blood. 2010;116(20):4175–4184. doi:10.1182/blood-2010-01-266098
   PubMed Web of Science ®Google Scholar
• Koenders MI, Lubberts E, Oppers-Walgreen B, et al. Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1. Am J Pathol. 2005;167(1):141–149. doi:10.1016/S0002-9440(10)62961-6
   PubMed Web of Science ®Google Scholar
• Hofstetter HH, Ibrahim SM, Koczan D, et al. Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis. Cell Immunol. 2005;237(2):123–130. doi:10.1016/j.cellimm.2005.11.002
   PubMed Web of Science ®Google Scholar
• Dang EV, Barbi J, Yang HY, et al. Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell. 2011;146(5):772–784. doi:10.1016/j.cell.2011.07.033
   PubMed Web of Science ®Google Scholar
• Nagle DG, Zhou YD. Natural product-based inhibitors of hypoxia-inducible factor-1 (HIF-1). Curr Drug Targets. 2006;7(3):355–369. doi:10.2174/138945006776054979
   PubMed Web of Science ®Google Scholar
• Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003;3(10):721–732. doi:10.1038/nrc1187
   PubMed Web of Science ®Google Scholar
• Giaccia A, Siim BG, Johnson RS. HIF-1 as a target for drug development. Nat Rev Drug Discov. 2003;2(10):803–811. doi:10.1038/nrd1199
   PubMed Web of Science ®Google Scholar
• Powis G, Kirkpatrick L. Hypoxia inducible factor-1alpha as a cancer drug target. Mol Cancer Ther. 2004;3(5):647–654. doi:10.1158/1535-7163.647.3.5
   PubMed Web of Science ®Google Scholar
• Yeo EJ, Chun YS, Park JW. New anticancer strategies targeting HIF-1. Biochem Pharmacol. 2004;68(6):1061–1069. doi:10.1016/j.bcp.2004.02.040
   PubMed Web of Science ®Google Scholar
• Panossian A, Wikman G, Sarris J. Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy. Phytomedicine. 2010;17(7):481–493. doi:10.1016/j.phymed.2010.02.002
   PubMed Web of Science ®Google Scholar
• Pu WL, Zhang MY, Bai RY, et al. Anti-inflammatory effects of Rhodiola rosea L.: A review. Biomed Pharmacother. 2020;121:109552. doi:10.1016/j.biopha.2019.109552
   PubMed Web of Science ®Google Scholar
• Li Y, Pham V, Bui M, et al. Rhodiola rosea L.: an herb with anti-stress, anti-aging, and immunostimulating properties for cancer chemoprevention. Curr Pharmacol Rep. 2017;3(6):384–395. doi:10.1007/s40495-017-0106-1
   PubMedGoogle Scholar
• Olsson EM, von Scheele B, Panossian AG. A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract shr-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue. Planta Med. 2009;75(2):105–112. doi:10.1055/s-0028-1088346
   PubMed Web of Science ®Google Scholar
• Kosakowska O, Baczek K, Przybyl JL, et al. Antioxidant and antibacterial activity of roseroot (Rhodiola rosea L.) dry extracts. Molecules. 2018;23(7):1767–1781.
   PubMed Web of Science ®Google Scholar
• Khanna K, Mishra KP, Ganju L, et al. Golden root: a wholesome treat of immunity. Biomed Pharmacother. 2017;87:496–502. doi:10.1016/j.biopha.2016.12.132
   PubMed Web of Science ®Google Scholar
• Song D, Zhao M, Feng L, et al. Salidroside attenuates acute lung injury via inhibition of inflammatory cytokine production. Biomed Pharmacother. 2021;142:111949. doi:10.1016/j.biopha.2021.112045
   PubMed Web of Science ®Google Scholar
• Li X, Sipple J, Pang Q, et al. Salidroside stimulates DNA repair enzyme parp-1 activity in mouse HSC maintenance. Blood. 2012;119(18):4162–4173.
   PubMed Web of Science ®Google Scholar
• Xie N, Fan F, Jiang S, et al. Rhodiola crenulate alleviates hypobaric hypoxia-induced brain injury via adjusting NF-kappaB/NLRP3-mediated inflammation. Phytomedicine. 2022;103:154240.
   PubMed Web of Science ®Google Scholar
• Radomska-Lesniewska DM, Skopinski P, Balan BJ, et al. Angiomodulatory properties of Rhodiola spp. and other natural antioxidants. Cent Eur J Immunol. 2015;40(2):249–262.
   PubMed Web of Science ®Google Scholar
• Kumar H, Choi DK. Hypoxia inducible factor pathway and physiological adaptation: a cell survival pathway? Mediators Inflamm. 2015;2015:584758. doi:10.1155/2015/520618
   PubMed Web of Science ®Google Scholar
• Qi YJ, Cui S, Lu DX, et al. Effects of the aqueous extract of a Tibetan herb, Rhodiola algida var. tangutica on proliferation and HIF-1alpha, HIF-2alpha expression in MCF-7 cells under hypoxic condition in vitro. Cancer Cell Int. 2015;15:81. doi:10.1186/s12935-015-0225-x
   PubMed Web of Science ®Google Scholar
• Zhang L, Xie XS, Li FY, et al. Effects of salidroside on tubular epithelial to myofibroblast transition under cobaltous chloride induced hypoxic status. Sichuan Da Xue Xue Bao Yi Xue Ban. 2010;41(1):43–48.
   PubMedGoogle Scholar
• Killick SB, Bown N, Cavenagh J, et al. Guidelines for the diagnosis and management of adult aplastic anaemia. Br J Haematol. 2016;172(2):187–207. doi:10.1111/bjh.13853
   PubMed Web of Science ®Google Scholar
• Ben-Shoshan J, Maysel-Auslender S, Mor A, et al. Hypoxia controls CD4 + CD25 + regulatory T-cell homeostasis via hypoxia-inducible factor-1alpha. Eur J Immunol. 2008;38(9):2412–2418. doi:10.1002/eji.200838318
   PubMed Web of Science ®Google Scholar
• You X, Yang Q, Yan K, et al. Multi-omics profiling identifies pathways associated with CD8(+) T-cell activation in severe aplastic anemia. Front Genet. 2021;12:790990.
   PubMed Web of Science ®Google Scholar
• Yang J, Zhang L, Wang H, et al. Protective effects of chronic intermittent hypobaric hypoxia pretreatment against aplastic anemia through improving the adhesiveness and stress of mesenchymal stem cells in rats. Stem Cells Int. 2017;2017:5706193.
   PubMed Web of Science ®Google Scholar
• Liu Z, Li X, Simoneau AR, et al. Rhodiola rosea extracts and salidroside decrease the growth of bladder cancer cell lines via inhibition of the mTOR pathway and induction of autophagy. Mol Carcinog. 2012;51(3):257–267. doi:10.1002/mc.20780
   PubMed Web of Science ®Google Scholar
• Fan XJ, Wang Y, Wang L, et al. Salidroside induces apoptosis and autophagy in human colorectal cancer cells through inhibition of PI3 K/Akt/mTOR pathway. Oncol Rep. 2016;36(6):3559–3567. doi:10.3892/or.2016.5138
   PubMed Web of Science ®Google Scholar
• Skopinska-Rozewska E, Malinowski M, Wasiutynski A, et al. The influence of Rhodiola quadrifida 50% hydro-alcoholic extract and salidroside on tumor-induced angiogenesis in mice. Pol J Vet Sci. 2008;11(2):97–104.
   PubMed Web of Science ®Google Scholar
• Chen X, Kou Y, Lu Y, et al. Salidroside ameliorated hypoxia-induced tumorigenesis of BxPC-3 cells via downregulating hypoxia-inducible factor (HIF)-1alpha and LOXL2. J Cell Biochem. 2020;121(1):165–173. doi:10.1002/jcb.29000
   PubMed Web of Science ®Google Scholar
• Qin Y, Liu HJ, Li M, et al. Salidroside improves the hypoxic tumor microenvironment and reverses the drug resistance of platinum drugs via HIF-1alpha signaling pathway. EBioMedicine. 2018;38:25–36. doi:10.1016/j.ebiom.2018.10.069
   PubMed Web of Science ®Google Scholar
• Zhong X, Lin R, Li Z, et al. Effects of Salidroside on cobalt chloride-induced hypoxia damage and mTOR signaling repression in PC12 cells. Biol Pharm Bull. 2014;37(7):1199–1206. doi:10.1248/bpb.b14-00100
   PubMed Web of Science ®Google Scholar
• Tang Y, Vater C, Jacobi A, et al. Salidroside exerts angiogenic and cytoprotective effects on human bone marrow-derived endothelial progenitor cells via Akt/mTOR/p70S6 K and MAPK signalling pathways. Br J Pharmacol. 2014;171(9):2440–2456. doi:10.1111/bph.12611
   PubMed Web of Science ®Google Scholar
• Xu MC, Shi HM, Wang H, et al. Salidroside protects against hydrogen peroxide-induced injury in HUVECs via the regulation of REDD1 and mTOR activation. Mol Med Rep. 2013;8(1):147–153. doi:10.3892/mmr.2013.1468
   PubMed Web of Science ®Google Scholar
• Zheng XT, Wu ZH, Wei Y, et al. Induction of autophagy by salidroside through the AMPK-mTOR pathway protects vascular endothelial cells from oxidative stress-induced apoptosis. Mol Cell Biochem. 2017;425(1-2):125–138. doi:10.1007/s11010-016-2868-x
   PubMed Web of Science ®Google Scholar
• Zheng KY, Zhang ZX, Guo AJ, et al. Salidroside stimulates the accumulation of HIF-1alpha protein resulted in the induction of EPO expression: a signaling via blocking the degradation pathway in kidney and liver cells. Eur J Pharmacol. 2012;679(1-3):34–39. doi:10.1016/j.ejphar.2012.01.027
   PubMed Web of Science ®Google Scholar
• Zhang J, Kasim V, Xie YD, et al. Inhibition of PHD3 by salidroside promotes neovascularization through cell-cell communications mediated by muscle-secreted angiogenic factors. Sci Rep. 2017;7:43935. doi:10.1038/srep43935
   PubMed Web of Science ®Google Scholar
• Krause A, Scaletta N, Ji JD, et al. Rheumatoid arthritis synoviocyte survival is dependent on Stat3. J Immunol. 2002;169(11):6610–6616. doi:10.4049/jimmunol.169.11.6610
   PubMed Web of Science ®Google Scholar
• Harada T, Kyttaris V, Li Y, et al. Increased expression of STAT3 in SLE T cells contributes to enhanced chemokine-mediated cell migration. Autoimmunity. 2007;40(1):1–8. doi:10.1080/08916930601095148
   PubMed Web of Science ®Google Scholar
• Frisullo G, Angelucci F, Caggiula M, et al. pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity. J Neurosci Res. 2006;84(5):1027–1036. doi:10.1002/jnr.20995
   PubMed Web of Science ®Google Scholar
• Harris TJ, Grosso JF, HR Y, et al. Cutting edge: An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity. J Immunol. 2007;179(7):4313–4317. doi:10.4049/jimmunol.179.7.4313
   PubMed Web of Science ®Google Scholar
• Gu Y, Hu X, Liu C, et al. Interleukin (IL)-17 promotes macrophages to produce IL-8, IL-6 and tumour necrosis factor-alpha in aplastic anaemia. Br J Haematol. 2008;142(1):109–114. doi:10.1111/j.1365-2141.2008.07161.x
   PubMed Web of Science ®Google Scholar
• Gao M, Ge M, Huo J, et al. Leptin-mediated proinflammatory bone marrow environment in acquired aplastic anemia. Cytokine. 2022;152:155829.
   PubMed Web of Science ®Google Scholar
• Qi Z, Qi S, Ling L, et al. Salidroside attenuates inflammatory response via suppressing JAK2-STAT3 pathway activation and preventing STAT3 transfer into nucleus. Int Immunopharmacol. 2016;35:265–271. doi:10.1016/j.intimp.2016.04.004
   PubMed Web of Science ®Google Scholar
• Hirano T. IL-6 in inflammation, autoimmunity and cancer. Int Immunol. 2021;33(3):127–148. doi:10.1093/intimm/dxaa078
   PubMed Web of Science ®Google Scholar
• Grivennikov S, Karin E, Terzic J, et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell. 2009;15(2):103–113. doi:10.1016/j.ccr.2009.01.001
   PubMed Web of Science ®Google Scholar
• Johnson DE, O'Keefe RA, Grandis JR. Targeting the IL-6/JAK/STAT3 signalling axis in cancer. Nat Rev Clin Oncol. 2018;15(4):234–248. doi:10.1038/nrclinonc.2018.8
   PubMed Web of Science ®Google Scholar
• Hirano T, Ishihara K, Hibi M. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene. 2000;19(21):2548–2556. doi:10.1038/sj.onc.1203551
   PubMed Web of Science ®Google Scholar
• Jenkins BJ, Roberts AW, Greenhill CJ, et al. Pathologic consequences of STAT3 hyperactivation by IL-6 and IL-11 during hematopoiesis and lymphopoiesis. Blood. 2007;109(6):2380–2388. doi:10.1182/blood-2006-08-040352
   PubMed Web of Science ®Google Scholar
• Gupta V, Kumar S, Sonowal R, et al. Interleukin-6 and interleukin-8 levels correlate with the severity of aplastic anemia in children. J Pediatr Hematol Oncol. 2017;39(3):214–216. doi:10.1097/MPH.0000000000000724
   PubMed Web of Science ®Google Scholar
• Yan X, Liu J, Zhu M, et al. Salidroside orchestrates metabolic reprogramming by regulating the Hif-1alpha signalling pathway in acute mountain sickness. Pharm Biol. 2021;59(1):1540–1550.
   PubMed Web of Science ®Google Scholar
• Qian EW, Ge DT, Kong SK. Salidroside protects human erythrocytes against hydrogen peroxide-induced apoptosis. J Nat Prod. 2012;75(4):531–537. doi:10.1021/np200555s
   PubMed Web of Science ®Google Scholar
• Qian EW, Ge DT, Kong SK. Salidroside promotes erythropoiesis and protects erythroblasts against oxidative stress by up-regulating glutathione peroxidase and thioredoxin. J Ethnopharmacol. 2011;133(2):308–314. doi:10.1016/j.jep.2010.09.025
   PubMed Web of Science ®Google Scholar
• Dame C, Kirschner KM, Bartz KV, et al. Wilms tumor suppressor, Wt1, is a transcriptional activator of the erythropoietin gene. Blood. 2006;107(11):4282–4290. doi:10.1182/blood-2005-07-2889
   PubMed Web of Science ®Google Scholar
• Sasaki R, Masuda S, Nagao M. Erythropoietin: multiple physiological functions and regulation of biosynthesis. Biosci Biotechnol Biochem. 2000;64(9):1775–1793. doi:10.1271/bbb.64.1775
   PubMed Web of Science ®Google Scholar
• Tang H, Gao L, Mao J, et al. Salidroside protects against bleomycin-induced pulmonary fibrosis: activation of Nrf2-antioxidant signaling, and inhibition of NF-kappaB and TGF-beta1/smad-2/-3 pathways. Cell Stress Chaperones. 2016;21(2):239–249. doi:10.1007/s12192-015-0654-4
   PubMed Web of Science ®Google Scholar
• Suragani RN, Cadena SM, Cawley SM, et al. Transforming growth factor-beta superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis. Nat Med. 2014;20(4):408–414. doi:10.1038/nm.3512
   PubMed Web of Science ®Google Scholar
• Verma A, Suragani RN, Aluri S, et al. Biological basis for efficacy of activin receptor ligand traps in myelodysplastic syndromes. J Clin Invest. 2020;130(2):582–589. doi:10.1172/JCI133678
   PubMed Web of Science ®Google Scholar
• Khodadi E, Shahrabi S, Shahjahani M, et al. Role of stem cell factor in the placental niche. Cell Tissue Res. 2016;366(3):523–531. doi:10.1007/s00441-016-2429-3
   PubMed Web of Science ®Google Scholar
• Hitchcock IS, Kaushansky K. Thrombopoietin from beginning to end. Br J Haematol. 2014;165(2):259–268. doi:10.1111/bjh.12772
   PubMed Web of Science ®Google Scholar
• Yang YC, Clark SC. Human interleukin 3: analysis of the gene and its role in the regulation of hematopoiesis. Int J Cell Cloning. 1990;8(Suppl 1)):121–128, 128–129.
   PubMedGoogle Scholar
• De R, Dutta A, Dolai TK, et al. Comparative study of bone marrow and blood plasma levels of IL-2 in aplastic anaemia and their relationship with disease severity. Hematology. 2019;24(1):84–88. doi:10.1080/10245332.2018.1512391
   PubMed Web of Science ®Google Scholar
• Maciejewski JP, Sloand EM, Nunez O, et al. Recombinant humanized anti-IL-2 receptor antibody (daclizumab) produces responses in patients with moderate aplastic anemia. Blood. 2003;102(10):3584–3586. doi:10.1182/blood-2003-04-1032
   PubMed Web of Science ®Google Scholar